Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview.
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
The benefits of exercise training in multiple sclerosis.
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles.
Tumor-like multiple sclerosis.
Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.
Noninvasive molecular imaging of neuroinflammation.
Myelination of the nervous system: mechanisms and functions.
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
[Inflammatory brain pseudotumor. A variant of demyelinating disease that simulates high-grade glioma].
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis.
Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.
Individual variation of human sphingosine 1-phosphate receptor 1 coding sequence leads to heterogeneity in receptor function and drug interactions.
Gray matter is targeted in first-attack multiple sclerosis.
Naltrexone
Paroxysmal Hypothermia in Two Patients with Multiple Sclerosis.
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
Genzyme to Resubmit LemtradaTM Application for FDA Review
Building a better sphingosine kinase-1 inhibitor.
Pediatric multiple sclerosis in Venezuela.

Pages